摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3aα,4β,6aα)-1,3-dibenzylhexahydro-4-(3-methoxypropyl)-1H-thieno<3,4-d>imidazol-2(3H)-one | 288392-52-9

中文名称
——
中文别名
——
英文名称
(3aα,4β,6aα)-1,3-dibenzylhexahydro-4-(3-methoxypropyl)-1H-thieno<3,4-d>imidazol-2(3H)-one
英文别名
(3aS,4S,6aR)-1,3-Dibenzyl-4-(3-methoxy-propyl)-tetrahydro-1H-thieno<3,4-d>imidazol-2(3H)-on;(3aS)-1,3-dibenzyl-4t-(3-methoxy-propyl)-(3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-one;(3aS,4S,6aR)-1,3-dibenzyl-4-(3-methoxypropyl)-3a,4,6,6a-tetrahydrothieno[3,4-d]imidazol-2-one
(3aα,4β,6aα)-1,3-dibenzylhexahydro-4-(3-methoxypropyl)-1H-thieno<3,4-d>imidazol-2(3H)-one化学式
CAS
288392-52-9
化学式
C23H28N2O2S
mdl
——
分子量
396.554
InChiKey
UBZGJYPBSVGCSL-FKBYEOEOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    28
  • 可旋转键数:
    8
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    58.1
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    (3AS-cis)-1,3-dibenzyltetrahydro-4-(3-methoxypropylidene)-1H-thieno(3,4-d)imidazol-2(3H)-one氢气sodium acetate 、 palladium(II) hydroxide 作用下, 以 甲醇 为溶剂, 20.0 ℃ 、500.01 kPa 条件下, 以93.6%的产率得到(3aα,4β,6aα)-1,3-dibenzylhexahydro-4-(3-methoxypropyl)-1H-thieno<3,4-d>imidazol-2(3H)-one
    参考文献:
    名称:
    [EN] A PROCESS FOR PRODUCING D-BIOTIN INTERMEDIATES
    [FR] PROCÉDÉ DE PRODUCTION D'INTERMÉDIAIRES DE D-BIOTINE
    摘要:
    The present invention provides a process for producing a biotin intermediate compound of formula (I), or a geometrical isomer thereof or a geometrical isomeric mixture thereof in the presence of a catalyst, wherein R1 and R1' are independently H, lower alkyl, aryl or acyl group, optionally substituted by one or more substituents; and R2 is lower alkyl optionally substituted by lower alkoxyl or carboxyl group. According to the present invention, the process surprisingly reduces the reaction pressure while maintaining high yield and selectivity in industrial scale, and thus saves investment on facility and increases safety in industry.
    公开号:
    WO2021224295A1
点击查看最新优质反应信息

文献信息

  • Diarylcuprates for Selective Syntheses of Multifunctionalized Ketones from Thioesters under Mild Conditions
    作者:Daiki Kato、Tomoya Murase、Jalindar Talode、Haruki Nagae、Hayato Tsurugi、Masahiko Seki、Kazushi Mashima
    DOI:10.1002/chem.202200474
    日期:2022.5.6
    copper-mediated ketone synthesis could be applied to the synthesis of not only gluconolactone-derived ketone 6, a synthetic intermediate in the transformation to the SGLT2 inhibitor canagliflozin, but also thiolactol 8, a valuable synthetic intermediate for (+)-biotin. Control experiments on an isolated diphenylcuprate(I), [CuPh2 ]- (12), and DFT calculations revealed that this ketone synthesis proceeded
    通过使用在环境温度下以 1:1.3-1.5 的比例从 (I) 盐和芳基格氏试剂原位生成的二芳基酸盐 (I) 从酯选择性地合成酮。在酮合成过程中,各种官能团,如羰基(酮、酯和酰胺)、O-保护基、卤素和杂芳烃,都可以以优异的收率得到多官能化酮。这种介导的酮合成不仅可用于合成葡萄糖酸内酯衍生的酮 6(一种转化为 SGLT2 抑制剂卡格列净的合成中间体),还可以用于合成硫代乳酸 8(一种有价值的 (+)-生物素合成中间体)。对分离的二苯酸盐 (I)、[CuPh2]- (12) 的对照实验,
  • Versuche zur Biotinsynthese. Herstellung von (3aS, 6aR)-1, 3-Dibenzyl-tetrahydro-4H-thieno[3, 4-d]imidazol-2,4(1H)-dion
    作者:M. Gerecke、J.-P. Zimmermann、W. Aschwanden
    DOI:10.1002/hlca.19700530514
    日期:——
    AbstractA modification of the biotin synthesis of Goldberg & Sternbach is described, enantiomers being separated in the first steps and wrong isomers recyclised. The conversion of the lactone 15 to the thiolactone 16 is done by a new method using potassium thioacetate in high boiling solvents.
  • WO2022/260168
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多

同类化合物

生物素-C5-叠氮 樟磺咪芬 四氢-4-(5-羟戊基)-(3AS,4S,6AR)-1H-噻吩并[3,4-D]咪唑-2(3H)-酮 咪噻吩 利地霉素 5-硫杂-1,2A-二氮杂环戊并[Cd]并环戊二烯 1,3-二苄基-4-羟基-4-(3-甲氧基丙基)四氢-1H-噻吩并[3,4-d]咪唑-2(3H)-酮 1,3-二苄基-2-氧代十氢噻吩并[1',2':1,2]噻吩并[3,4-d]咪唑-5-鎓溴化物 (3aS-顺式)-1,3-二苄基四氢-4-(3-甲氧基丙亚基)-1H-噻吩并[3,4-d]咪唑-2(3H)-酮 (3AS,4S,6AR)-1,3-二苄基-2-氧代六氢-1H-噻吩并[3,4-d]咪唑-4-甲醛 3,4-(N-Monobenzyl-2'-oxoimidazolido)-2-(4-hydroxybutyl)-thiophan (1R,3R)-3-Cyclopentylidenemethyl-2,2-dimethyl-cyclopropanecarboxylic acid 2,5-dioxo-3-prop-2-ynyl-imidazolidin-1-ylmethyl ester (+/-)-1,3-dibenzyl-2-oxo-(3ar,8ac,8bc)-decahydro-thieno[1',2':1,2]thieno[3,4-d]imidazolium; chloride cis 1,3-Dibenzyl-4-diphenylphosphinoylmethyl-2,3,3a,4,6,6a-hexahydrofuro<3,4-d>imidazol-2-one 7-[3-(3-hydroxy-3-methyl-nonyl)-1-methyl-2,5-dioxo-imidazolidin-4-yl]-heptanoic acid ethyl ester biotin thioacetate 5-((3aS)-1,3-dibenzyl-2-oxo-(3ar,6ac)-hexahydro-selenolo[3,4-d]imidazol-4t-yl)-pentanoic acid 2,5,5-trioxo-(3ar,6ac)-hexahydro-5λ6-thieno[3,4-d]imidazole-1-carboxylic acid ethyl ester (1'S,3aS,4R,6aR)-4-(1'-hydroxypentyl)-1H-tetrahydrothieno<3,4-d>imidazol-2(3H)-one [4-((3aR,6S,6aS)-2-Oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-butyl]-carbamic acid 2-(2-hydroxy-ethoxy)-ethyl ester biotin thiol (3aS,4S,6aR)-4-(6-bromohexyl)-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one (1'R,3aS,4R,6aR)-4-(1'-hydroxypentyl)-1H-tetrahydrothieno<3,4-d>imidazol-2(3H)-one 4t-(3-acetoxy-propyl)-1,3-dibenzyl-(3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-one 6-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]hexanenitrile (S)-α-<<3aR-(3aα,4α,6aα)>-2-Hexahydro-2-oxo-1,3-bis(phenylmethyl)-1H-thieno<3,4-d>imidazol-4-yloxy>benzeneacetic acid 3,4-(1,3-Diallyl-2-oxoimidazolido)-thiophan cis-N-benzylperhydrothieno<3,4-d>imidazole-2-one 5,5-dioxide 3-((3aS)-1,3-dibenzyl-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-propionic acid 6,6-dioxo-(4ar,7ac)-hexahydro-6λ6-thieno[3,4-d]pyrimidine-2,4-dione (3aα,4α,6aα)-1,3-dibenzylhexahydro-4-(pentyloxy)-1H-thieno<3,4-d>imidazol-2(3H)-one 3,4-(1',3'-Dibenzyl-2'-oxoimidazolido)-2-thiophanvaleronitril 4t-(3-acetoxy-propyl)-1,3-dibenzyl-(3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-one 3-(1,3-dibenzyl-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-propionaldehyde 1,3-dibenzyl-4,6,7,8,8a,8b-hexahydro-3aH-thieno[5,6]thieno[1,2-b]imidazol-5-ium-2-one,bromide (3aS)-1,3-dibenzyl-4t-(3-hydroxy-propyl)-(3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-one (3aR)-1,3-dibenzyl-2-oxo-(3ar,8ac,8bc)-decahydro-thieno[1',2':1,2]thieno[3,4-d]imidazolium, (1R)-2-oxo-bornane-10-sulfonate 5-((3aS)-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-pent-2-enoic acid methyl ester 3,3a,4,6,7,8,8a,8b-octahydro-1H-thieno[5,6]thieno[1,2-b]imidazol-5-ium-2-one,bromide 5ξ-hydroxy-(2ar,7ac,7bc)-hexahydro-1-thia-3,4a-diaza-cyclopenta[cd]inden-4-one 5-((3aS)-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-pent-2t-enoic acid methyl ester 1,3-Dibenzyl-6-(bis-phenylsulfanyl-methyl)-tetrahydro-thieno[3,4-d]imidazol-2-one (4Z)-1-ethyl-5-imino-4-({3-methoxy-4-[(2-methylbenzyl)oxy]phenyl}methylidene)imidazolidin-2-one [3-((3aS)-1,3-dibenzyl-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-propyl]-malonic acid (3aS,6aR)-1-Allyl-5,5-dioxo-hexahydro-5λ6-thieno[3,4-d]imidazol-2-one 3-(2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-propionaldehyde oxime cis-(3a,6a)-1,3-di-n-butylhexahydro-1H-thieno<3,4-d>imidazole 5,5-dioxide